Insider trading

Period: 120 months Stock: PLRX Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

42 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

42 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

42 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

42 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
42 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
42 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

42 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2023
Coulie Bernard President and CEO
Sold, plan not stated 2×
$504.20K 15,000 at 33.61
5.9%
2 Feb 2023
Coulie Bernard President and CEO
Sold, plan not stated 2×
$513.23K 15,000 at 34.22
5.9%
1 Feb 2023
Coulie Bernard President and CEO
Sold, plan not stated 3×
$515.77K 15,000 at 34.38
5.9%
31 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated
$523.76K 15,000 at 34.92
5.9%
30 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated 2×
$512.12K 15,000 at 34.14
5.9%
27 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated 2×
$535.29K 15,000 at 35.69
5.9%
27 Jan 2023
Coulie Bernard President and CEO · indirect
Sold, plan not stated 2×
$351.26K 10,000 at 35.13
2.4%
26 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated
$529.37K 15,000 at 35.29
5.9%
26 Jan 2023
Coulie Bernard President and CEO · indirect
Sold, plan not stated
$526.43K 15,000 at 35.10
3.5%
25 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated 2×
$487.52K 15,000 at 32.50
13.8%
24 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated
$463.39K 15,000 at 30.89
13.8%
23 Jan 2023
Lefebvre Eric Chief Medical Officer
Sold, plan not stated
$2.33M 67,500 at 34.48
46.7%
23 Jan 2023
Cummings Keith Lamont Chief Financial Officer
Sold, plan not stated
$1.05M 30,000 at 35.00
26.2%
23 Jan 2023
Ouimette Mike General Counsel & Corp. Sec'y
Sold, plan not stated
$683.88K 20,000 at 34.19
77.1%
Sold half or more
23 Jan 2023
Coulie Bernard President and CEO · indirect
Sold, plan not stated
$525.00K 15,000 at 35.00
3.3%
23 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated 2×
$511.57K 15,000 at 34.10
13.8%
9 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated
$95.83K 5,000 at 19.17
5.1%
6 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated
$285.58K 15,000 at 19.04
13.8%
4 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated
$285.94K 15,000 at 19.06
13.8%
3 Jan 2023
Coulie Bernard President and CEO
Sold, plan not stated
$289.95K 15,000 at 19.33
13.8%
22 Dec 2022
Ouimette Mike General Counsel & Corp. Sec'y
Sold, plan not stated
$56.73K 2,928 at 19.38
33.0%
20 Dec 2022
Coulie Bernard President and CEO
Sold, plan not stated
$653.53K 34,212 at 19.10
26.7%
20 Dec 2022
Lefebvre Eric Chief Medical Officer
Sold, plan not stated
$207.97K 10,887 at 19.10
7.0%
20 Dec 2022
Cummings Keith Lamont Chief Financial Officer
Sold, plan not stated
$184.20K 9,643 at 19.10
10.7%
20 Dec 2022
Hull Hans Chief Business Officer
Sold, plan not stated
$167.11K 8,748 at 19.10
6.0%
20 Dec 2022
Ouimette Mike General Counsel & Corp. Sec'y
Sold, plan not stated
$90.14K 4,719 at 19.10
34.7%
25 Oct 2022
Lefebvre Eric Chief Medical Officer
Sold, plan not stated
$125.24K 5,000 at 25.05
3.6%
12 Sep 2022
Coulie Bernard President and CEO
Sold, plan not stated
$281.85K 12,502 at 22.54
17.4%
12 Jul 2022
Coulie Bernard President and CEO
Sold, plan not stated
$281.21K 12,498 at 22.50
17.4%
11 Jul 2022
Coulie Bernard President and CEO
Sold, plan not stated
$337.50K 15,000 at 22.50
20.2%
11 Jul 2022
Lefebvre Eric Chief Medical Officer
Sold, plan not stated
$60.00K 3,000 at 20.00
2.1%
18 Jun 2021
Lefebvre Eric Chief Medical Officer
Sold, plan not stated 3×
$360.82K 12,500 at 28.87
8.4%
14 Jun 2021
Coulie Bernard President and CEO · indirect
Sold, plan not stated 2×
$132.10K 4,000 at 33.03
0.9%
14 May 2021
Coulie Bernard President and CEO · indirect
Sold, plan not stated 2×
$100.22K 3,500 at 28.64
0.8%
14 Apr 2021
Coulie Bernard President and CEO · indirect
Sold, plan not stated
$106.16K 3,500 at 30.33
0.8%
18 Mar 2021
Lefebvre Eric Chief Medical Officer
Sold, plan not stated 2×
$492.68K 12,500 at 39.41
7.7%
15 Mar 2021
Coulie Bernard President and CEO · indirect
Sold, plan not stated 3×
$134.83K 3,500 at 38.52
0.8%
16 Feb 2021
Coulie Bernard President and CEO · indirect
Sold, plan not stated 3×
$114.35K 3,500 at 32.67
0.7%
14 Jan 2021
Coulie Bernard President and CEO · indirect
Sold, plan not stated 2×
$92.33K 3,500 at 26.38
0.7%
18 Dec 2020
Lefebvre Eric Chief Medical Officer
Sold, plan not stated 2×
$331.75K 12,500 at 26.54
7.2%
14 Dec 2020
Coulie Bernard President and CEO · indirect
Sold, plan not stated 2×
$95.79K 3,500 at 27.37
0.7%
1 Dec 2020
Cummings Keith Lamont Chief Financial Officer
Sold, plan not stated 4×
$562.04K 18,734 at 30.00
99.9%
Sold half or more
Showing 1–42 of 42.